Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward Ottimo Pharma has appointed Robert Tighe and Katherine Bell-McGuinn to enhance its leadership, advancing the innovative cancer therapy Jankistomig.

Ottimo Pharma Appoints Veteran Leaders to Propel Unique Cancer Therapy Forward #London #United_Kingdom #Leadership_Team #Ottimo_Pharma #Jankistomig

Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment Ottimo Pharma has raised over $140 million in Series A funding to develop innovative bifunctional cancer treatments, led by prominent investors.

Ottimo Pharma Secures Over $140 Million in Series A Funding to Revolutionize Cancer Treatment #London #cancer_therapy #United_Kingdom #Ottimo_Pharma #Jankistomig